Diabetic Retinopathy - Arbour, Jean Daniel
15,99 €
inkl. MwSt.

Versandfertig in über 4 Wochen
payback
8 °P sammeln
  • Broschiertes Buch

Approximately 2.4 million Canadians suffer from diabetes and are likely to develop diabetic retinopathy. This disease of the retina caused by diabetes affects 99 percent of people with type 1 diabetes and 60 percent of those with type 2 diabetes in the first 20 years after the onset of diabetes. Early detection has thus become a major issue in the fight against diabetic retinopathy, especially since very effective treatments are available that can not only slow progression of the disease but also even restore lost vision. Written in simple and clear language, by doctors specializing in eye…mehr

Andere Kunden interessierten sich auch für
Produktbeschreibung
Approximately 2.4 million Canadians suffer from diabetes and are likely to develop diabetic retinopathy. This disease of the retina caused by diabetes affects 99 percent of people with type 1 diabetes and 60 percent of those with type 2 diabetes in the first 20 years after the onset of diabetes. Early detection has thus become a major issue in the fight against diabetic retinopathy, especially since very effective treatments are available that can not only slow progression of the disease but also even restore lost vision. Written in simple and clear language, by doctors specializing in eye disorders, this book covers all aspects of the disease and provides important information for those who have diabetic retinopathy and people close to them.
Autorenporträt
Dr. Jean Daniel Arbour heads the ophthalmology department of the faculty of medicine at the University of Montreal, where he is also associate professor. After receiving his M.D. from the University of Montreal, Dr. Arbour interned in general surgery, specialized in ophthalmology and then went to Harvard University in the United States for medical and surgical retina training. At Harvard, Dr. Arbour also conducted research on macular degeneration and photodynamic and antiangiogenic therapy. Dr. Arbour is currently vitreoretinal surgeon at Notre-Dame Hospital, which is part of the University of Montreal hospital centre (CHUM). He is also the founder of the hospital's ophthalmology research centre, where he has been the principal investigator in genetic studies of wet AMD and numerous international studies of new treatments in macular degeneration and diabetic retinopathy. The author of many articles published in medical journals, Dr. Arbour has also given more than 70 national and international scientific conferences on retinal disease. Dr. Arbour was president of the Quebec association of ophthalmologists from 2005 to 2009. He is currently treasurer of the Canadian Ophthalmological Society.